• Rocket Lab shares are under pressure. Why is RKLB stock retreating?

SpaceX IPO Weighs On Rocket Lab

Rocket Lab has been under pressure, down 13% over the past month, as investors shift money away from smaller launch providers amid speculation that SpaceX could pursue a $1.5 trillion IPO.

Additionally, Congress’s recent decision to withhold funding for NASA’s planned 2031 Mars sample-return mission has led to a reassessment of Rocket Lab’s long-term opportunities in deep space.

Earnings Loom With Bullish Targets

The countdown is on: Rocket Lab is set to report earnings on Thursday after the market close.

• EPS Estimate: Loss of 9 cents (up from Loss of 10 cents)
• Revenue Estimate: $178.07 million (up from $132.39 million)

Analyst Consensus & Recent Actions: The stock carries a Buy Rating with an average price target of $64.00. Recent analyst moves include:

• Goldman Sachs: Neutral (Raises Target to $69.00) (Jan. 20)
• B of A Securities: Buy (Raises Target to $120.00) (Jan. 20)
• Morgan Stanley: Upgraded to Overweight (Raises Target to $105.00) (Jan. 16)

Mixed Signals Despite Strong Gains

The stock is currently trading 8.6% below its 50-day simple moving average (SMA) and 6.3% above its 100-day SMA, indicating a mixed technical picture.

Shares have increased 206.69% over the past 12 months and are currently positioned closer to their 52-week highs than lows.

The RSI is at 45.80, which is considered neutral territory. Meanwhile, MACD is at -1.9718, below its signal line at -1.4466, indicating bearish pressure on the stock.

The combination of neutral RSI and bearish MACD suggests mixed momentum, indicating that traders should be cautious.

• Key Resistance: $80.00
• Key Support: $67.00

RKLB Shares Slip Tuesday

RKLB Price Action: Rocket Lab shares were down 2.93% at $68.15 at the time of publication on Tuesday, according to Benzinga Pro data.

Image: Shutterstock